Literature DB >> 17286096

Inhibition of hepatitis C IRES-mediated gene expression by 8-17 deoxyribozymes in human tissue culture cells.

A V Vlassov1, H Ilves, B H Johnston.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17286096     DOI： 10.1134/s1607672906050012

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN： 1607-6729            Impact factor:   0.788


× No keyword cloud information.
  10 in total

1.  A new and efficient DNA enzyme for the sequence-specific cleavage of RNA.

Authors:  A R Feldman; D Sen
Journal:  J Mol Biol       Date:  2001-10-19       Impact factor: 5.469

Review 2.  Approaches for the sequence-specific knockdown of mRNA.

Authors:  Lisa J Scherer; John J Rossi
Journal:  Nat Biotechnol       Date:  2003-12       Impact factor: 54.908

3.  Catalytic DNA and RNA for targeting MDR1 mRNA.

Authors:  M Kuznetsova; A Fokina; M Lukin; M Repkova; A Venyaminova; V Vlassov
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2003 May-Aug       Impact factor: 1.381

Review 4.  Ribozyme- and deoxyribozyme-strategies for medical applications.

Authors:  S Schubert; J Kurreck
Journal:  Curr Drug Targets       Date:  2004-11       Impact factor: 3.465

Review 5.  Ribozymes, DNAzymes and small interfering RNAs as therapeutics.

Authors:  Mouldy Sioud; Per Ole Iversen
Journal:  Curr Drug Targets       Date:  2005-09       Impact factor: 3.465

6.  A general purpose RNA-cleaving DNA enzyme.

Authors:  S W Santoro; G F Joyce
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

7.  Small hairpin RNAs efficiently inhibit hepatitis C IRES-mediated gene expression in human tissue culture cells and a mouse model.

Authors:  Qian Wang; Christopher H Contag; Heini Ilves; Brian H Johnston; Roger L Kaspar
Journal:  Mol Ther       Date:  2005-09       Impact factor: 11.454

Review 8.  Challenges and successes in developing new therapies for hepatitis C.

Authors:  Raffaele De Francesco; Giovanni Migliaccio
Journal:  Nature       Date:  2005-08-18       Impact factor: 49.962

9.  Dinucleotide junction cleavage versatility of 8-17 deoxyribozyme.

Authors:  Rani P G Cruz; Johanna B Withers; Yingfu Li
Journal:  Chem Biol       Date:  2004-01

Review 10.  Antisense technologies. Improvement through novel chemical modifications.

Authors:  Jens Kurreck
Journal:  Eur J Biochem       Date:  2003-04
  10 in total
  1 in total

1.  Sequence-function relationships provide new insight into the cleavage site selectivity of the 8-17 RNA-cleaving deoxyribozyme.

Authors:  Kenny Schlosser; Jimmy Gu; Lauren Sule; Yingfu Li
Journal:  Nucleic Acids Res       Date:  2008-01-18       Impact factor: 16.971
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.